Xenetic Biosciences, Inc. Forecast, price target & analysts
$2.46
7.87%
today
Nasdaq,
Apr 03, 03:45 pm CET
Xenetic Biosciences, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
Xenetic Biosciences, Inc. Classifications & Recommendation:
Hold
100%
Xenetic Biosciences, Inc. Price Target
| Target Price | $40.00 |
| Price | $2.67 |
| Potential |
1,398.13%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Xenetic Biosciences, Inc. price target 2026.
The average Xenetic Biosciences, Inc. target price is $40.00.
This is
1,398.13%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Xenetic Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Xenetic Biosciences, Inc. stock has an average upside potential 2026 of
1,398.13%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.50 | 2.80 |
| 1.57% | 12.00% | |
| EBITDA Margin | -140.00% | -196.43% |
| 21.33% | 40.31% |
1 Analyst has issued a sales forecast Xenetic Biosciences, Inc. 2025 . The average Xenetic Biosciences, Inc. sales estimate is
$2.8m
Unlock
12.00%
higher
Unlock
$2.8m
12.00%
Unlock
$2.8m
12.00%
Unlock
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Xenetic Biosciences, Inc. 2025 . The average Xenetic Biosciences, Inc. EBITDA estimate is
$-5.5m
Unlock
57.14%
lower
Unlock
$-5.5m
57.14%
Unlock
$-5.5m
57.14%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Current Xenetic Biosciences, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 22 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 20 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 05 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 22 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 20 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
